T0	Participants 85 117	symptomatic atrial fibrillation.
T1	Participants 262 286	atrial fibrillation (AF)
T2	Participants 378 470	Patients with symptomatic paroxysmal or persistent AF who had converted to sinus rhythm (SR)
T3	Participants 617 728	Of the 141 patients from 36 participating centers, 47 were given aprindine, 47 digoxin, and 47 were on placebo.